This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Akiyama, T Articles by Yamamoto, T Search for Related Content PubMed PubMed Citation Articles by Akiyama, T Articles by Yamamoto, T

The transforming potential of the c-erbB-2 protein is regulated by its autophosphorylation at the carboxyl-terminal domain.

Department of Oncogene Research, Osaka University, Japan.

ABSTRACT

The mutant c-erbB-2 protein with Glu instead of Val-659 exhibited transforming activity in NIH 3T3 cells. This protein showed enhanced tyrosine kinase activity in vitro and enhanced autophosphorylation at Tyr-1248 located proximal to the carboxyl terminus. Enhanced tyrosine phosphorylation of several cellular proteins was detected in cells expressing the Glu-659 c-erbB-2 protein. Introduction of an additional mutation at the ATP-binding site (Lys-753 to Met) of this protein resulted in abolition of its transforming ability. These data indicate that the transforming potential of c-erbB-2 is closely correlated with elevated tyrosine kinase activity of the gene product. To investigate the role of autophosphorylation in cell transformation, we introduced an additional mutation at the autophosphorylation site of the Glu-659 c-erbB-2 protein (Tyr-1248 to Phe). This mutant protein exhibited lower tyrosine kinase activity and lower transforming activity. On the other hand, when the carboxyl-terminal 230 amino acid residues were deleted from the c-erbB-2 protein, the tyrosine kinase activity and cell-transforming activity of the protein were enhanced. Thus, the carboxyl-terminal domain, which contains the major autophosphorylation site, Tyr-1248, may regulate cellular transformation negatively and autophosphorylation may eliminate this negative regulation.

This article has been cited by other articles:

• Trowe, T., Boukouvala, S., Calkins, K., Cutler, R. E. Jr., Fong, R., Funke, R., Gendreau, S. B., Kim, Y. D., Miller, N., Woolfrey, J. R., Vysotskaia, V., Yang, J. P., Gerritsen, M. E., Matthews, D. J., Lamb, P., Heuer, T. S. (2008). EXEL-7647 Inhibits Mutant Forms of ErbB2 Associated with Lapatinib Resistance and Neoplastic Transformation. Clin. Cancer Res. 14: 2465-2475 [Abstract] [Full Text]  
• Scaltriti, M., Rojo, F., Ocana, A., Anido, J., Guzman, M., Cortes, J., Di Cosimo, S., Matias-Guiu, X., Ramon y Cajal, S., Arribas, J., Baselga, J. (2007). Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer. JNCI J Natl Cancer Inst 99: 628-638 [Abstract] [Full Text]  
• Funes, M., Miller, J. K., Lai, C., Carraway, K. L. III, Sweeney, C. (2006). The Mucin Muc4 Potentiates Neuregulin Signaling by Increasing the Cell-surface Populations of ErbB2 and ErbB3. J. Biol. Chem. 281: 19310-19319 [Abstract] [Full Text]  
• Klos, K. S., Wyszomierski, S. L., Sun, M., Tan, M., Zhou, X., Li, P., Yang, W., Yin, G., Hittelman, W. N., Yu, D. (2006). ErbB2 Increases Vascular Endothelial Growth Factor Protein Synthesis via Activation of Mammalian Target of Rapamycin/p70S6K Leading to Increased Angiogenesis and Spontaneous Metastasis of Human Breast Cancer Cells. Cancer Res. 66: 2028-2037 [Abstract] [Full Text]  
• Yokoyama, N., Ischenko, I., Hayman, M. J., Miller, W. T. (2005). The C Terminus of RON Tyrosine Kinase Plays an Autoinhibitory Role. J. Biol. Chem. 280: 8893-8900 [Abstract] [Full Text]  
• Tan, M., Li, P., Klos, K. S., Lu, J., Lan, K.-H., Nagata, Y., Fang, D., Jing, T., Yu, D. (2005). ErbB2 Promotes Src Synthesis and Stability: Novel Mechanisms of Src Activation That Confer Breast Cancer Metastasis. Cancer Res. 65: 1858-1867 [Abstract] [Full Text]  
• Chan, R., Hardy, W. R., Dankort, D., Laing, M. A., Muller, W. J. (2004). Modulation of Erbb2 signaling during development: a threshold level of Erbb2 signaling is required for development. Development 131: 5551-5560 [Abstract] [Full Text]  
• Meyer, R. D., Singh, A. J., Rahimi, N. (2004). The Carboxyl Terminus Controls Ligand-dependent Activation of VEGFR-2 and Its Signaling. J. Biol. Chem. 279: 735-742 [Abstract] [Full Text]  
• Ren, Z., Schaefer, T. S. (2002). ErbB-2 Activates Stat3alpha in a Src- and JAK2-dependent Manner. J. Biol. Chem. 277: 38486-38493 [Abstract] [Full Text]  
• Kim, S., Zagozdzon, R., Meisler, A., Baleja, J. D., Fu, Y., Avraham, S., Avraham, H. (2002). Csk Homologous Kinase (CHK) and ErbB-2 Interactions Are Directly Coupled with CHK Negative Growth Regulatory Function in Breast Cancer. J. Biol. Chem. 277: 36465-36470 [Abstract] [Full Text]  
• Niu, X.-L., Peters, K. G., Kontos, C. D. (2002). Deletion of the Carboxyl Terminus of Tie2 Enhances Kinase Activity, Signaling, and Function. EVIDENCE FOR AN AUTOINHIBITORY MECHANISM. J. Biol. Chem. 277: 31768-31773 [Abstract] [Full Text]  
• Penuel, E., Akita, R. W., Sliwkowski, M. X. (2002). Identification of a Region within the ErbB2/HER2 Intracellular Domain That Is Necessary for Ligand-independent Association. J. Biol. Chem. 277: 28468-28473 [Abstract] [Full Text]  
• Thor, A. D., Liu, S., Edgerton, S., Moore, D. II, Kasowitz, K. M., Benz, C. C., Stern, D. F., DiGiovanna, M. P. (2000). Activation (Tyrosine Phosphorylation) of ErbB-2 (HER-2/neu): A Study of Incidence and Correlation With Outcome in Breast Cancer. JCO 18: 3230-3239 [Abstract] [Full Text]  
• Kim, S.-O., Houtman, J. C. D., Jiang, J., Ruppert, J. M., Bertics, P. J., Frank, S. J. (1999). Growth Hormone-induced Alteration in ErbB-2 Phosphorylation Status in 3T3-F442A Fibroblasts. J. Biol. Chem. 274: 36015-36024 [Abstract] [Full Text]  
• Zrihan-Licht, S., Deng, B., Yarden, Y., McShan, G., Keydar, I., Avraham, H. (1998). Csk Homologous Kinase, a Novel Signaling Molecule, Directly Associates with the Activated ErbB-2 Receptor in Breast Cancer Cells and Inhibits Their Proliferation. J. Biol. Chem. 273: 4065-4072 [Abstract] [Full Text]  
• Kwon, Y. K., Bhattacharyya, A., Alberta, J. A., Giannobile, W. V., Cheon, K., Stiles, C. D., Pomeroy, S. L. (1997). Activation of ErbB2 during Wallerian Degeneration of Sciatic Nerve. J. Neurosci. 17: 8293-8299 [Abstract] [Full Text]  
• Reese, D. M., Slamon, D. J. (1997). HER-2/neu Signal Transduction in Human Breast and Ovarian Cancer. Stem Cells 15: 1-8 [Abstract] [Full Text]  
• Kavanaugh, W., Turck, C., Williams, L. (1995). PTB domain binding to signaling proteins through a sequence motif containing phosphotyrosine. Science 268: 1177-1179 [Abstract]  
• Gilboa, L., Ben-Levy, R., Yarden, Y. (1995). Roles for a Cytoplasmic Tyrosine and Tyrosine Kinase Activity in the Interactions of Neu Receptors with Coated Pits. J. Biol. Chem. 270: 7061-7067 [Abstract] [Full Text]